<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 20 Jul 2026 16:05:20 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics names new CFO, promotes executive, and loses legal chief</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</link>
   <description>

&lt;p&gt;Neuronetics, Inc. (NASDAQ: STIM) announced several management changes, including the appointment of Nir Naor as Chief Financial Officer, effective July 23, 2026.&lt;/p&gt;

&lt;p&gt;Naor brings more than 20 years of finance and life sciences experience. He most recently served as CFO of Axogen (NASDAQ: AXGN), a peripheral nerve repair company, where he contributed to the company achieving profitability and cash flow positivity within one year. Previously, he held CFO roles at Arbor Pharmaceuticals, where he led its sale to Azurity Pharmaceuticals, and at the U.S./Americas business of Mölnlycke. Earlier in his career, he held senior finance roles at UCB and AstraZeneca, worked</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+names+new+CFO%2C+promotes+executive%2C+and+loses+legal+chief/26789703.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience&lt;/li&gt;&lt;li&gt;Cory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 2026&lt;/li&gt;&lt;li&gt;Andrew Macan to step down as Executive Vice President, Chief Legal Officer &amp;amp; Corporate Secretary, effective August 15, 2026&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;MALVERN, Pa., July  20, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that Nir Naor will be</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience&lt;/li&gt;&lt;li&gt;Cory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 2026&lt;/li&gt;&lt;li&gt;Andrew Macan to step down as Executive Vice President, Chief Legal Officer &amp;amp; Corporate Secretary, effective August 15, 2026&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;MALVERN, Pa., July  20, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that Nir Naor will be</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience&lt;/li&gt;&lt;li&gt;Cory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 2026&lt;/li&gt;&lt;li&gt;Andrew Macan to step down as Executive Vice President, Chief Legal Officer &amp;amp; Corporate Secretary, effective August 15, 2026&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;MALVERN, Pa., July  20, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that Nir Naor will be</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience&lt;/li&gt;&lt;li&gt;Cory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 2026&lt;/li&gt;&lt;li&gt;Andrew Macan to step down as Executive Vice President, Chief Legal Officer &amp;amp; Corporate Secretary, effective August 15, 2026&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;MALVERN, Pa., July  20, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that Nir Naor will be</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience&lt;/li&gt;&lt;li&gt;Cory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 2026&lt;/li&gt;&lt;li&gt;Andrew Macan to step down as Executive Vice President, Chief Legal Officer &amp;amp; Corporate Secretary, effective August 15, 2026&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;MALVERN, Pa., July  20, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that Nir Naor will be</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience&lt;/li&gt;&lt;li&gt;Cory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 2026&lt;/li&gt;&lt;li&gt;Andrew Macan to step down as Executive Vice President, Chief Legal Officer &amp;amp; Corporate Secretary, effective August 15, 2026&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;MALVERN, Pa., July  20, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that Nir Naor will be</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience&lt;/li&gt;&lt;li&gt;Cory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 2026&lt;/li&gt;&lt;li&gt;Andrew Macan to step down as Executive Vice President, Chief Legal Officer &amp;amp; Corporate Secretary, effective August 15, 2026&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;MALVERN, Pa., July  20, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that Nir Naor will be</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience&lt;/li&gt;&lt;li&gt;Cory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 2026&lt;/li&gt;&lt;li&gt;Andrew Macan to step down as Executive Vice President, Chief Legal Officer &amp;amp; Corporate Secretary, effective August 15, 2026&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;MALVERN, Pa., July  20, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that Nir Naor will be</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience&lt;/li&gt;&lt;li&gt;Cory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 2026&lt;/li&gt;&lt;li&gt;Andrew Macan to step down as Executive Vice President, Chief Legal Officer &amp;amp; Corporate Secretary, effective August 15, 2026&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;MALVERN, Pa., July  20, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that Nir Naor will be</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+Appoints+Nir+Naor+Chief+Financial+Officer%3B+Announces+Additional+Management+Changes/26789693.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04758039</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28503203</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36189357</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36549092</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AXGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00092737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01848302</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15658009</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22202258</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.29459406</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47642696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
 </channel>
</rss>
